United States
US 12,697,350 B2
Methods and compositions for treating a premature termination codon-mediated disorder
US 12,697,350 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-04. Applicant: Tevard Biosciences, Inc. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- Tevard Biosciences, Inc.
- Inventors
- Sean McFarland; Ying-Hsin Chen; Peter M. Eimon
- Publication date
- 2026-08-04
- Filing date
- 2022-04-29
- Document type
- B2 Granted patent
- Also written as
- US 12,697,350 B2 · US12697350 · 12697350
Abstract
The invention relates generally to modified tRNAs and the use of modified tRNAs to express in a mammalian cell a functional gene product encoded by a gene containing a premature termination codon and/or to treat a disease mediated by a premature termination codon, e.g., Dravet syndrome.
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free